You are here

Home » Safety information

COVID-19 treatments

20 August 2021

The Therapeutic Goods Administration (TGA) will rigorously assess any COVID-19 treatment for safety, quality and effectiveness before it can be registered for use in Australia. This page will be regularly updated to keep consumers, health professionals and sponsors informed of the latest regulatory developments.

For links to the latest information on all COVID-19 related work being undertaken by the TGA and the Department of Health, please visit the COVID-19 hub.

Provisional determinations

COVID-19 treatments that have received a provisional determination from the TGA

Provisional registrations

COVID-19 treatments that have been provisionally approved for use in Australia

Treatments undergoing evaluation

COVID-19 treatments undergoing evaluation for provisional registration by the TGA

Advertising compliance

Find information on complying with the rules around advertising COVID-19 treatments

Information for sponsors (industry)

Find information and guidance about the regulatory requirements and processes

Information for consumers and health professionals

Find out answers to the common types of questions you may have about how the TGA assesses and monitors a treatment for safety, quality and effectiveness

Report a side effect

The TGA continues to monitor the safety of medicines after they are registered in Australia so that we can detect and respond to any safety concerns. If you think you may be experiencing a significant side effect (also known as an adverse event) to a COVID-19 treatment, you should seek advice from your doctor. Further information about adverse events can be found on the Reporting adverse events web page.

If you think you have experienced a side effect from a COVID-19 treatment you can report it via:

  • Telephone: 1300 134 237 (8am-8pm seven days a week) – the NPS MedicineWise Adverse Medicine Events line
  • Online form: TGA adverse event reporting

Contact us

If you have an enquiry about the COVID-19 treatment regulatory process, use the following contact details:

  • Email: info@tga.gov.au
  • Telephone: 1800 020 653 (free call within Australia)

If you have a general enquiry about COVID-19 or the vaccine roll-out, contact the National Coronavirus Helpline on:

  • Telephone: 1800 020 080 (available 24 hours a day, seven days a week)